Answers are grounded in this paper and cite their sources.
Icodec insulin should be administered once-weekly, offering a convenient alternative to daily basal insulins. It effectively maintains glycemic control and demonstrates a similar safety profile, albeit with an increased incidence of mild hypoglycemia.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: